Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study
Recruiting
Phase 1
Interventional Study
Pain After Photorefractive Keratectomy
VAS Will be Used to Assess Pain Postoperative
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 64 (estimated)
- Sponsor
- Research Institute of Ophthalmology, Egypt · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The current study aims at assessing the efficacy and safety of oral Gabapentin alone versus Diclofenac Potassium drugs for postoperative analgesia in patients undergoing surface ablation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients over 18 years old
* preoperative stable refraction for at least one-year,
* normal corneal tomography with expected postoperative flat K reading not less than 38D, and postoperative residual stromal bed not less than 350 μm.
Exclusion Criteria:
* Patients with preop…
Contacts